Company Analysis

Valion Bio, Inc. (VBIO)

Nasdaq: VBIO · Electromedical & Electrotherapeutic Apparatus · San Antonio, TX · filing with the SEC since 2019
Grade3.4
◀ Past 2.1● Present 2.3▶ Future 6.0
2 est.

Who runs Valion Bio, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Zikria Dean
Interim CEO. First filing Nov 2021, latest Sep 24, 2026, 0 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
15 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Zikria DeanInterim CEONov 2021Sep 24, 2026none
Wolf Lisa GCOO & CFOOct 2024Sep 24, 2026none
Handley Michael KChief Executive OfficerFeb 2025May 20, 2026none
Lackey MelindaGeneral Counsel & SVP of LegalMay 2026May 4, 2026none
Ernst JenniferChief Executive OfficerNov 2021Dec 22, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Jensen ThomasdirectorSep 2026Sep 17, 2026none
Malbin Jared DaviddirectorSep 2026Sep 17, 2026none
Bolton SheryledirectorNov 2021Apr 20, 2026none
Valauri Christina RizopoulosdirectorJul 2024Apr 2, 2026none
Earlier names on the record7, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton VBIO · research, not advice